BiomX Inc. (PHGE) Reports Q1 Loss of $0.35

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to BiomX Inc. (PHGE) Reports Q1 Loss of $0.35

BiomX Reports First Quarter 2021 Financial Results and Provides Business Updates

May 24, 2021 6:30 AM EDT

- Company announces completion of enrollment for Phase 2 cosmetic clinical study of BX001 for acne-prone skin with results from 8-week treatment period expected in Q3 2021

- BiomX continues to anticipate clinical trial readouts in up to 4 different therapeutic indications by mid-2022

- Company will host a conference call and webcast today at 8:00 am ET

NESS ZIONA, Israel--(BUSINESS WIRE)-- BiomX Inc. (NYSE American: PHGE) (BiomX or the Company), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic... More